|

Assessment and Management of Multiple Drug Use in Elderly Chronic Disease Patients

RECRUITINGSponsored by Xijing Hospital
Actively Recruiting
SponsorXijing Hospital
Started2024-10-01
Est. completion2026-09-30
Eligibility
Age65 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07180368

Summary

The purpose of this observational study is to understand the impact of polypharmacy on the prognosis of elderly patients with chronic diseases. The main research question it aims to address is: Does polypharmacy affect the prognosis of elderly patients with chronic diseases? Elderly patients with chronic diseases will be asked to complete online survey questions regarding their disease prognosis over a 2-year period.

Eligibility

Age: 65 Years+Healthy volunteers accepted
Inclusion Criteria:

* Patients aged 65 years or older with at least one chronic disease

Exclusion Criteria:

* Patients without chronic diseases
* Patients refused to participate in the study
* Patients with unstable vital signs

Conditions12

COPDChronic Kidney DiseaseChronic Obstructive Pulmonary Disease (COPD)Coronary Artery DiseaseDiabete MellitusDiabetesHeart DiseaseHeart FailureHyperlipidemiaHypertension

Browse More Trials

Heart Disease trialsDiabetes trialsCOPD trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.